Analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens upped their price objective on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st.
View Our Latest Stock Analysis on Veradigm
Veradigm Trading Down 4.8 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Overbought Stocks Explained: Should You Trade Them?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What Does a Stock Split Mean?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
